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Abstract
Background: The free-living amoeba Balamuthia mandrillaris may cause fatal encephalitis both in
immunocompromised and in – apparently – immunocompetent humans and other mammalian
species. Rapid, specific, sensitive, and reliable detection requiring little pathogen-specific expertise
is an absolute prerequisite for a successful therapy and a welcome tool for both experimental and
epidemiological research.
Results: A real-time polymerase chain reaction assay using TaqMan® probes (real-time PCR) was
established specifically targeting the RNase P gene of B. mandrillaris amoebae. The assay detected
at least 2 (down to 0.5) genomes of B. mandrillaris grown in axenic culture. It did not react with
DNA from closely related Acanthamoeba (3 species), nor with DNA from Toxoplasma gondii,
Leishmania major, Pneumocystis murina, Mycobacterium bovis (BCG), human brain, various mouse
organs, or from human and murine cell lines. The assay efficiently detected B. mandrillaris DNA in
spiked cell cultures, spiked murine organ homogenates, B. mandrillaris-infected mice, and CNS
tissue-DNA preparations from 2 patients with proven cerebral balamuthiasis. This novel primer set
was successfully combined with a published set that targets the B. mandrillaris 18S rRNA gene in a
duplex real-time PCR assay to ensure maximum specificity and as a precaution against false negative
results.
Conclusion: A real-time PCR assay for B. mandrillaris amoebae is presented, that is highly specific,
sensitive, and reliable and thus suited both for diagnosis and for research.
Background
Balamuthiasis is a disease of humans and a variety of
mammalian species caused by the free-living amoeba
Balamuthia mandrillaris [1,2]. Its most important clinical
manifestation is Balamuthia amoebic encephalitis (BAE),
also described as granulomatous amebic encephalitis
(GAE), in both immunocompromized hosts and in indi-
viduals apparently without immunological deficits [3,4].
B. mandrillaris is exquisitely encephalotropic and cyto-
pathic [5], causing extensive brain tissue damage [6]. With
worldwide around 150 identified cases to date [7], BAE is
rare, however, with only 3 documented survivors [8,9],
exceedingly lethal. Due to lack of practical experience,
amoebic encephalitis is often mistaken for a brain
tumour, viral or bacterial encephalitis, tuberculoma, or
neurocysticercosis [3]. There exist no characteristic clinical
symptoms, nor laboratory, or radiological findings diag-
nostic of BAE [10]. The high percentage of fatal BAE cases
is also due to the high frequency of misdiagnosis and sub-
sequent false, possibly even exacerbating, treatment strat-
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egies. At the moment, a proper diagnosis is possible only
at autopsy, which is seldom done in most countries. Con-
versely, BAE is most likely severely under-diagnosed and
thus reviewed by some authors as a genuine emerging [11]
or at least potentially threatening [12] parasitic infection.
B. mandrillaris amoebae have recently been detected in
soils both in the close vicinity of and distant from a BAE
case [13,14]. Inhalation of contaminated dust or wound-
ing contact with contaminated soils are the likely sources
of infection. While infections of the skin and lungs may
prevail for months, the infection of the central nervous
system (CNS) can result in death in a matter of days [15].
As patients generally present first with neurological symp-
toms indicating that the CNS is already affected, rapid and
dependable diagnosis is an absolutely prerequisite for any
successful therapy.
Until recently, diagnosis of BAE relied on microscopical
analysis of brain tissue (biopsy and necropsy), with indi-
rect immunofluorescence (IIF) microscopy as the
favoured detection method [2,16,17]. Apart from specific
antiserum, this requires appreciable expertise, and a tissue
sample of sufficient quality. PCR-based methods have the
advantage of requiring much less pathogen-specific expe-
rience and can therefore be easily added to the diagnostic
panel of any laboratory equipped with the basic tools and
know-how. In addition, they are potentially more sensi-
tive and specific, and can analyse larger sample volumes.
Finally, they do not necessarily rely on intact pathogens
and are more likely to detect an infection, i.e. pathogen-
specific nucleic acid, in the blood or CSF, enabling less
invasive diagnostic procedures.
PCR-based methods are being increasingly used for
detecting known pathogenic amoebae [18-20]. To date, B.
mandrillaris PCRs generally target ribosomal RNA (rRNA)
gene sequences [17,21-24]. Even when quantification is
not necessary, real-time PCR should be given preference
over conventional PCR whenever possible, as the omis-
sion of post-amplification handling leads to quicker
results and reduces the risk of amplicon contamination
[24-26]. To identify false-positive results due to cross-reac-
tivity and to ensure that novel variants or mutants in the
target gene do not lead to false-negative results, the iden-
tification of microorganisms by PCR should involve the
detection of at least 2 independent areas of the pathogen's
genome in parallel. This becomes increasingly important
with the microorganisms pathogenicity, when misdiagno-
sis bears grave consequences [27,28]. Accordingly, a real-
time PCR assay was established specifically targeting the
RNase P gene [29] of B. mandrillaris and tested in normal
and spiked cell cultures, organ samples and patient mate-
rial. Furthermore, this new assay was compared to a
recently published real-time PCR targeting an 18S rRNA
gene sequence of B. mandrillaris [24], and a duplex assay
combining both was performed for optimal specificity
and reliability.
Results and discussion
The aim of this communication is to introduce a real-time
PCR-based assay for detecting infections with B. mandril-
laris amoebae with maximum specificity, sensitivity, and
reliability. For this, a partial RNase P gene sequence, pub-
lished in GenBank, was found containing a region(nucle-
otide 251 to nucleotide 328) specific for B. mandrillaris as
demonstrated by basic local alignment search tool
(BLAST) analysis. PCR primers and a TaqMan probe were
designed as described in Materials and Methods. The
enzyme RNase P is responsible for generating the mature
5'-end of tRNA by a single endonucleolytic cleavage of
their precursors. It is an essential, ubiquitous enzyme
present in all cells and cellular compartments that synthe-
size tRNA: bacterial cells, Archaea, eukaryotic nuclei, mito-
chondria, and chloroplasts. All known RNase P enzymes
are ribonucleoproteins containing an RNA subunit essen-
tial for catalysis [29]. Eukaryotic RNase P RNA contains a
conserved core structure as well as regions of highly varia-
ble length and structure [30].
The ability of the designed RNase P primer set to detect B.
mandrillaris  DNA was evaluated with trophozoites (ca.
10% cysts) from axenic culture. In more than 30 experi-
ments, less than 2 B. mandrillaris amoebae equivalents
were dependably detected, in individual experiments
down to 0.5. The RNase P primer set did not react with ≥
500 pg DNA from 3 different Acanthamoeba species, other
protozoa or mycobacteria, nor did it react with mamma-
lian tissues or cell lines. It did, however, detect B. mandril-
laris DNA in murine tissues spiked with B. mandrillaris
amoebae (summarized in Table 1). The genus Acan-
thamoeba is closely related to Balamuthia [31] and 25-fold
polyploid [32]. Assuming that a single B. mandrillaris cell
contains 25 copies of the RNase P gene, a sensitivity limit
of 2 amoebae or 50 gene copies seems reasonable.
To establish assay sensitivity in the presence of host tissue,
pieces of murine brain tissue were spiked with graded
numbers of B. mandrillaris from axenic cultures (contain-
ing up to 10% cysts) and RNase P and 18S rRNA genes
DNA detected in parallel by duplex real-time PCR. As
show in Fig 1A, down to 0.5 amoeba equivalents could be
detected when targeting both RNase P and 18S rRNA
genomic DNA.
Our results targeting the RNase P gene revealed a similar
sensitivity as those published by Qvarnstrom and col-
leagues for the 18S rRNA gene in a triplex real-time PCR
[24]. In direct comparison (duplex real-time PCR), how-
ever, the 18S rRNA gene primer set (Fig. 1B) regularly wasBMC Microbiology 2008, 8:210 http://www.biomedcentral.com/1471-2180/8/210
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more sensitive by 2.5 to 4 cycles than the RNase P gene
primer set (Fig. 1A). The 18S rRNA gene is 24-fold repeti-
tive in A. castellanii [33]. Assuming B. mandrillaris to be
25-fold polyploid, one cell would contain 600 copies of
the 18S rRNA gene. A 10-fold difference in gene copies
normally results in a difference in sensitivity by 2–3 cycles
in the real-time PCR. Thus the assumed 24-fold surplus of
18S rRNA genes per cell might well explain the somewhat
lower sensitivity of the RNase P gene primer set.
These promising in vitro results encouraged testing stored
material from experimentally infected animals. For exam-
ple, a brain necropsy specimen that had been kept frozen
at -70°C for over 3 years from an intranasally infected
mouse that had shown neurological symptoms of BAE
before death, and whose brains had been found to be
infected with B. mandrillaris amoeba by IIF microscopy,
also gave positive results by real-time PCR (Table 2). All
specimens from noninfected mouse brains were negative.
Next, the real-time PCR assay was applied to fresh brain
biopsy specimens from a tumor patient without or with
added B. mandrillaris amoebae. Human brain tissue had
no effect on the assay, as it neither produced false negative
results nor inhibited the detection of B. mandrillaris DNA
(Table 2). Finally, DNA from brain biopsies of 2 BAE
patients [23] (Table 1: cases 4 and 5) were tested positive
for B. mandrillaris RNase P genes (Table 2). Highly similar
results were achieved with a second primer set batch, this
time using Cy5/BHQ-2 for dye/quencher (data not
shown). No differences in assay sensitivity were detected
between B. mandrillaris DNA from human or baboon BAE
cases, supporting the concept of a single genotype for B.
mandrillaris [34].
Conclusion
This TaqMan real-time PCR assay using a primer set
designed to target a B. mandrillaris-specific region of the
RNase P gene, detects B. mandrillaris genomes in amoeba
cultures, spiked tissues, and infected brain tissue with
high specificity and sensitivity. In direct comparison with
a published primer set that targets the 18S rRNA gene of
B. mandrillaris, this assay is somewhat less sensitive, which
can be explained by the different expected genome num-
bers per cell of the respective target genes. Both primer sets
were successfully combined in a duplex real-time PCR
assay to ensure maximum specificity and as a precaution
against false negative results.
Methods
Mice
Female C57BL/6 wild-type (WT) and immunodeficient
C57BL/6 rag1-/- (RAG) mice aged 8–12 weeks and bred at
the Central Animal Facility (ZVZ), Federal Institute for
Risk Assessment (BfR), Berlin, were kept in individually
ventilated cages (Bio A.S., Ehret, Emmendingen, Ger-
many) in the animal facility of the Robert Koch Institute.
Housing materials, food and drink (both given ad libitum)
were sterilized by autoclaving or irradiating before use,
and all handling was performed in a class-II safety cabinet.
Cells, microorganisms, and clinical specimens
B. mandrillaris (CDC-V039; ATCC 50209) was grown in
Chang's special medium as described [5]. Acanthamoeba
hatchetti  (strain 2HH; ATCC PRA-113), A. lenticulata
(strain 72/2; ATCC 50705), and A. castellanii (strain 1BU;
ATCC PRA-113) were kindly provided by Julia Walochnik,
Clinical Institute of Hygiene, University of Vienna, Aus-
tria, and grown axenically in PYG medium as described
Table 1: Balamuthia mandrillaris RNase P genomic DNA detected by real-time PCR – specificity and detection limits
DNA
[pg] a)
Amoebae
equivalents b)
CT c)
B. mandrillaris (axenic culture) 5 – 50 < 2 35 – 38
Acanthamoeba hatchetti 2HH (axenic culture) ≥ 500 neg ≥ 39
A. lenticulata 72/2 (axenic culture) ≥ 500 neg ≥ 39
A. castellanii 1BU (axenic culture) ≥ 500 neg ≥ 39
Toxoplasma gondii (partially purified) ≥ 500 neg ≥ 39
Leishmania major (axenic culture) ≥ 500 neg ≥ 39
Pneumocystis murina (partially purified) ≥ 500 neg ≥ 39
Mycobacterium bovis (BCG) ≥ 500 neg ≥ 39
Murine macrophage RAW 264.7 cells (TIB 71) ≥ 500 neg ≥ 39
Human neuroblastoma Kelly cells (ACC 355) ≥ 500 neg ≥ 39
Brain tissue (mouse, ca. 15 mm3) ≥ 500 neg ≥ 39
Brain tissue spiked with 1–10 B.m. n.d. 1 – 10 33 – 38
Lung, liver, spinal chord (mouse, ca. 15 mm3)>  5 0 0 n e g ≥ 39
Lung tissue spiked with 10 B.m. n.d. 10 35–36
a) Minimal amounts of total DNA giving positive results (CT < 39). b) Minimal numbers of amoebae (calculated as amoeba DNA equivalents per PCR 
tube) giving positive results; neg = CT ≥ 39 for at least 500 ng total DNA. c) Range of CT values measured; neg = CT ≥ 39 or no DNA detected; n.d. 
= not done.BMC Microbiology 2008, 8:210 http://www.biomedcentral.com/1471-2180/8/210
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[35]. Murine macrophage-like RAW 264.7 cells (ATCC TIB
71) and human neuroblastoma Kelly cells (DSMZ ACC
355) were grown in humidified, CO2-enriched (5%) nor-
mal atmosphere at 37°C in R10 consisting of RPMI 1640
medium (Gibco BRL-Life Technologies, Paisley, UK) sup-
plemented with 10% (v/v) fetal calf serum (FCS; Boe-
hringer Mannheim, Mannheim, Germany), 10 mM Na-
pyruvate (Sigma-Aldrich, Steinheim, Germany), 100 IU/
ml penicillin, and 100 μg/ml streptomycin (both Gibco).
Leishmania major LV39 strain was grown at 25°C in R10.
Pneumocystis murina organisms, originally kindly provided
by E. Dei-Cas, INSERM Unit 42, Villeneuve d'Ascq,
France, were contained in partially purified lung homoge-
nates from experimentally infected RAG mice. Mycobacte-
rium bovis BCG (Copenhagen) was grown at 37°C in
Middlebrook medium containing 10% ADC enrichment
(Becton Dickinson). PCR-tested Toxoplasma gondii (RH-
strain) DNA and total DNA from the ileum of T. gondii-
infected mice was kindly provided by O. Liesenfeld and U.
Lohmann, Department of Microbiology and Hygiene,
Charité University Medicine Berlin, Germany.
Balamuthia mitochondrial 16S rRNA gene-positive total
DNA extracted from brain tissue of two reported BAE
patients ([23] Table 1: cases 4 and 5) was kindly provided
by S. Yagi, California Department of Health Services,
Richmond, USA.
Extraction of DNA
DNA from normal human brain tissue, mouse tissues, cell
lines, and amoebae was isolated by a modification of the
UNSET procedure [36] as described by Walochnik and
coworkers [19]. Briefly, tissue samples of approximately
2.5 × 2.5 × 2.5 mm or the indicated number of cells were
solubilized at room temperature (RT) in 500 μl UNSET
lysis buffer (8 M urea, 0.15 M NaCl, 2% SDS, 0.001 M
EDTA, 0.1 M Tris/HCl; pH 7.5) by repeated (1–2 min)
pipetting using a 1 ml disposable pipette tip until a quasi
homogenous liquid was achieved. This was overlaid with
250 μl phenol and 250 μl chloroform (PC), and shaken
gently (rocking table) for 3–5 h at RT. DNA was extracted
by multiple PC-extraction followed by a single chloro-
form-extraction and precipitated in a 2.5-fold volume of
100% ethanol and a 0.1-fold volume of 3 M Na-acetate
(pH 4.8 – 5.3) over night at -20°C, and then centrifuged
for 30 min at 12,000 × g and 4°C. The supernatant was
aspirated and the pellet washed with 2 ml of 70% ethanol,
vortexed, and centrifuged for 5 min at 12,000 × g and 4°C.
Alcohol was removed by aspiration and the open tubes
placed in a laminar air-flow cabinet for ca. 10 min to evap-
orate the remaining alcohol before adding ca. 30 μl
ddH2O (depending on the expected quantity of DNA).
The DNA concentration was determined in a UV/Vis spec-
trophotometer (ND-1000, NanoDrop Technologies,
Wilmington, USA). DNA from BCG was extracted as
described by Somerville et al. [37].
Infection of mice with B. mandrillaris amoebae
Intranasal infection with B. mandrillaris (CDC-V039 was
performed as described [38]. In short, 5 × 103 amoebae
(~10% cysts) in 7.5 μl saline were injected into each nos-
tril of CD4-depleted (experimental details will be pub-
lished elsewhere) anesthetized mice using an Eppendorf
pipette fitted with an ultra-micro tip (Eppendorf-Neth-
eler-Hinz, Hamburg, Germany). Around 14 days later,
when the mice had become severely ill, they were first
anesthetized, then exsanguinated, and individual organs
or ~15 mm3 blocks thereof shock-frozen in liquid nitro-
gen and stored at -70°C for over 3 years.
Real-time PCR assay
B. mandrillaris sequences published in GenBank include
rRNA gene sequences and a partial RNase P gene
Detection of B. mandrillaris RNase P (A)and 18S rRNA gene  (B) DNA by duplex real-time PCR Figure 1
Detection of B. mandrillaris RNase P (A)and 18S 
rRNA gene (B) DNA by duplex real-time PCR. Ampli-
fication curves of murine brain tissue (ca. 15 mm3) alone 
(closed diamonds) or spiked with 500 (closed squares), 50 
(open squares), 5 (closed triangles), and 0,5 (open triangles) 
axenically cultured B. mandrillaris (calculated as amoeba DNA 
equivalents per PCR tube). Results from 3 separate experi-
ments.
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sequence. A nucleotide-nucleotide BLAST analysis with
the partial RNase P gene sequence (accession AF440362)
revealed the region from nucleotide 251 to nucleotide
328 to be specific for B. mandrillaris. Particularly, this
region was specific for B. mandrillaris also with respect to
the Acanthamoeba sequences available in the nucleotide
databases. The sequence of this specific DNA region was
exported to the Primer Express software (Applied Biosys-
tems, Foster City, CA, USA) for the design of the PCR
primers and a TaqMan probe. The selected primers RNase
P/FW (5'-GGC AGG TTC CGA GGA GAC A-3') and RNase
P/RV (5'-GTG GCC TTG TGT ATT GAA CTT AAC ATT-3')
amplify a 82 bp region and were used together with the
FAM/TAMRA-labelled TaqMan probe RNase P/Probe (5'-
Fam-TGG AAC CAT ACC TTG GGT GAC ACG ATG-
Tamra-3').
For comparison and design of a duplex real-time PCR
assay, the primers and probe recently published by Qvarn-
strom et al. [24] were used, whereby the probe was
labelled with HEX/BHQ: BalaF1451/FW (5'-TAA CCT
GCT AAA TAG TCA TGC CAA T-3'), BalaR1621/RV (5'-
CAA ACT TCC CTC GGC TAA TCA-3', and BalaP1582/
Probe (5'-Hex-AG TAC TTC TAC CAA TCC AAC CGC CA-
Bhq1-3').
The PCR reactions were performed using the ABsolute™
QPCR Mix from ABgene (Epsom, UK) according to the
manufacturer's instructions in a total volume of 50 μl. The
reaction mix contained 0.4 μM of each primer and 0.1 μM
of the probe. PCR runs were performed in the Mx3005P
real-time thermocycler from Stratagene (La Jolla, CA,
USA) with one hold at 95°C for 15 min and 40 cycles at
95°C for 15 sec (denaturation) followed by 60°C for 1
min (annealing/elongation). The fluorescence data were
collected at the end of the annealing/elongation step.
Data were analyzed and plotted with the MxPro software
from Stratagene.
Abbreviations
BAE: Balamuthia amoebic encephalitis; BCG: Bacille Cal-
mette-Guérin; BLAST: basic local alignment research tool;
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